B. Braun Ambulantes Herzzentrum Kassel MVZ GmbH
Kassel 34121
1 studies enrolling now · 5 studies all time
What they study most
Atherosclerotic Cardiovascular Disease, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Heart Failure With Preserved Ejection Fraction (HFpEF) and Diabetes Mellitus, Type 2, Hypertension, Obesity
Studies at this site
- EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease — Recruiting now
- Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction (OCEAN(a)) - Outcomes Trial — Running, not enrolling
- Research Study to Investigate How Well Semaglutide Works in People Living With Heart Failure and Obesity — Completed
- Research Study to Look at How Well Semaglutide Works in People Living With Heart Failure, Obesity and Type 2 Diabetes — Completed
- A Cross-sectional Study of Lipoprotein(a) Levels in Patients With Documented History of Atherosclerotic Cardiovascular Disease (ASCVD) — Completed